HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

galactonic acid

RN given refers to parent cpd without isomeric designation

Also Known As:

galactonic acid, (D)-isomer; galactonic acid, (L)-isomer; galactonic acid, monopotassium salt

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Hydroxy Acids: 94
    - Sugar Acids: 4
      - galactonic acid: 4
  - Acyclic Acids
    - Sugar Acids: 4
      - galactonic acid: 4
Carbohydrates: 22023
- Sugar Acids: 4
  - galactonic acid: 4

Experts

1.	Bell, Graeme I: 1 article (06/2015)
2.	Fahrmann, Johannes: 1 article (06/2015)
3.	Fiehn, Oliver: 1 article (06/2015)
4.	Grapov, Dmitry: 1 article (06/2015)
5.	Hammock, Bruce: 1 article (06/2015)
6.	Hara, Manami: 1 article (06/2015)
7.	Yang, Jun: 1 article (06/2015)

Related Diseases

1.	Galactosemias (Galactosemia) 05/12/1972 - "Galactonic Acid in galactosemia: identification in the urine." 09/24/1999 - "These infants did not excrete galactitol or galactonic acid into the urine, which is typical of hereditary galactosemia. "
2.	GM1 Gangliosidosis (Gangliosidosis GM1) 12/01/1987 - "For the leukocytes, our observations on enzyme inhibition by galactonic acid-y-lactone and derivatives of beta-D-galactose, together with an enzyme deficiency in GM1 gangliosidosis confirm the previous observation that beta-fuc and beta-gal are enzyme activities of a single protein (5). "
3.	Hypertriglyceridemia 06/01/2015 - "Key T1D-associated perturbations were related with 1) increases in oxidation products glucono-δ-lactone and galactonic acid and reductions in cysteine, methionine and threonic acid, suggesting increased oxidative stress; 2) reductions in circulating polyunsaturated fatty acids and lipid signaling mediators, most notably arachidonic acid (AA) and AA-derived eicosanoids, implying impaired states of systemic inflammation; 3) elevations in circulating triacylglyercides reflective of hypertriglyceridemia; and 4) reductions in major structural lipids, most notably lysophosphatidylcholines and phosphatidylcholines. "
4.	Inflammation (Inflammations) 06/01/2015 - "Key T1D-associated perturbations were related with 1) increases in oxidation products glucono-δ-lactone and galactonic acid and reductions in cysteine, methionine and threonic acid, suggesting increased oxidative stress; 2) reductions in circulating polyunsaturated fatty acids and lipid signaling mediators, most notably arachidonic acid (AA) and AA-derived eicosanoids, implying impaired states of systemic inflammation; 3) elevations in circulating triacylglyercides reflective of hypertriglyceridemia; and 4) reductions in major structural lipids, most notably lysophosphatidylcholines and phosphatidylcholines. "

Related Drugs and Biologics

1.	Lactones
2.	Arachidonic Acid (Vitamin F)
3.	Eicosanoids
4.	Proteins (Proteins, Gene)
5.	Phosphatidylcholines (Phosphatidylcholine)
6.	Methionine (L-Methionine)
7.	Lysophosphatidylcholines (Lysophosphatidylcholine)
8.	Lipids
9.	Galactose (Galactopyranose)
10.	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)